Castleark Management’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.56M Buy
+67,160
New +$2.83M 0.07% 196

Other funds holding DFTX

Castleark Management's DFTX Position: Q3 2026 in Review

Castleark Management opened a new position in Definium Therapeutics (DFTX) in Q3 2026: 67,160 shares worth $2.56M. The stake represents 0.07% of the portfolio and ranks #196 among its holdings.

354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Castleark Management held 67,160 shares of Definium Therapeutics worth $2.56M as of Q3 2026.
  • Definium Therapeutics was a new Castleark Management position in Q3 2026.
  • Definium Therapeutics made up 0.07% of Castleark Management's portfolio in Q3 2026, its #196 holding.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Castleark Management's 13F filing for Q3 2026, filed 16 Nov 2026.